Browsing byAuthorO'Neill, SM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)
2004-04-23Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: Propeptide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cellsCollins, PR; Stack, CM; O'Neill, SM; Doyle, S; Ryan, T; Brennan, GP; Mousley, A; Stewart, M; Maule, AG; Dalton, JP; Donnelly, S
2002-12-01Diagnosis of human fasciolosis in the Gilan province of Northern Iran: Application of cathepsin L-ELISARokni, MB; Massoud, J; O'Neill, SM; Parkinson, M; Dalton, JP
2016-10-01Fasciola hepatica surface tegument: Glycoproteins at the interface of parasite and hostRavida, A; Cwiklinski, K; Aldridge, AM; Clarke, P; Thompson, R; Gerlach, JQ; Kilcoyne, M; Hokke, CH; Dalton, JP; O'Neill, SM
2015-01-01Fasciola hepatica vaccine: We may not be there yet but we're on the right roadMolina-Hernández, V; Mulcahy, G; Pérez, J; Martínez-Moreno, Á; Donnelly, S; O'Neill, SM; Dalton, JP; Cwiklinski, K
2004-10-01Glycosidase activity in the excretory-secretory products of the liver fluke, Fasciola hepaticaIrwin, JA; Morrissey, PEW; Ryan, JP; Walshe, A; O'Neill, SM; Carrington, SD; Matthews, E; Fitzpatrick, E; Mulcahy, G; Corfield, AP; Dalton, JP
2008-11-01Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophagesDonnelly, S; Stack, CM; O'Neill, SM; Sayed, AA; Williams, DL; Dalton, JP
2010-01-29Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3Donnelly, S; O'Neill, SM; Stack, CM; Robinson, MW; Turnbull, L; Whitchurch, C; Dalton, JP
2003-01-01Helminth vaccines: From mining genomic information for vaccine targets to systems used for protein expressionDalton, JP; Brindley, PJ; Knox, DP; Brady, CP; Hotez, PJ; Donnelly, S; O'Neill, SM; Mulcahy, G; Loukas, A
2013-08-01Immunomodulatory molecules of Fasciola hepatica: Candidates for both vaccine and immunotherapeutic developmentDalton, JP; Robinson, MW; Mulcahy, G; O'Neill, SM; Donnelly, S
2018-04-01Infection by the helminth parasite fasciola hepatica requires rapid regulation of metabolic, virulence, and invasive factors to adjust to its mammalian hostCwiklinski, K; Jewhurst, H; McVeigh, P; Barbour, T; Maule, AG; Tort, J; O'Neill, SM; Robinson, MW; Donnelly, S; Dalton, JP
2010-02-01Major secretory antigens of the Helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responsesDowling, DJ; Hamilton, CM; Donnelly, S; La Course, J; Brophy, PM; Dalton, J; O'Neill, SM
2012-08-23Mechanisms of Immune Modulation by Fasciola hepatica: Importance for Vaccine Development and for Novel ImmunotherapeuticsRobinson, MW; Dalton, JP; O'Neill, SM; Donnelly, SM
2016-09-01A prospective view of animal and human FasciolosisCwiklinski, K; O'Neill, SM; Donnelly, S; Dalton, JP
2005-01-01Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophagesDonnelly, S; O'Neill, SM; Sekiya, M; Mulcahy, G; Dalton, JP